Effects of vitexin-2″-O-rhamnoside and vitexin-4″-O-glucoside on growth and oxidative stress-induced cell apoptosis of human adipose-derived stem cells

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 7, 2014, Pages 988-997

  Wei, Wenjuan ^a   Ying, Xixiang ^b   Zhang, Wenjie ^b   Chen, Yinghui ^b   Leng, Aijing ^a   Jiang, Chen ^a   Liu, Jing ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

cell toxicity; human adipose derived stem cells; oxidative stress; vitexin 2 O rhamnoside; vitexin 4 O glucoside

Indexed keywords

CASPASE 3; UNCLASSIFIED DRUG; VITEXIN; VITEXIN 2'' RHAMNOSIDE; VITEXIN 4'' O GLUCOSIDE; ANTIOXIDANT; APIGENIN; GLUCOSIDE; HYDROGEN PEROXIDE; ISOFLAVONE DERIVATIVE; ISOVITEXIN-4'-O-GLUCOSIDE; PLANT EXTRACT; VITEXIN RHAMNOSIDE;

ADIPOSE DERIVED STEM CELL; ADULT; ANTIAPOPTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG STRUCTURE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; OXIDATIVE STRESS; PLANT LEAF; ADIPOSE TISSUE; CHEMISTRY; CRATAEGUS; CYTOLOGY; DRUG EFFECTS; STEM CELL;

ADIPOSE TISSUE; ANTIOXIDANTS; APIGENIN; APOPTOSIS; CRATAEGUS; GLUCOSIDES; HUMANS; HYDROGEN PEROXIDE; ISOFLAVONES; OXIDATIVE STRESS; PLANT EXTRACTS; PLANT LEAVES; STEM CELLS;

EID: 84902545681     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12225     Document Type: Article

References (47)

1. Upton R,. Hawthorn Leaf with Flower: Analytical, Quality Control, and Therapeutic Monograph. Santa Cruz, CA: American Herbal Pharmacopoeia, 1999.
2. Zhang ZS, et al. Characterization of antioxidants present in hawthorn fruits. J Nutr Biochem 2001; 12: 144-152.
3. Liu PZ, et al. Characterization of phenolic compounds in Chinese hawthorn (Crataegus pinnatifida Bge. var. major) fruit by high performance liquid chromatography-electrospray ionization mass spectrometry. Food Chem 2010; 121: 1188-1197.
4. The Pharmacopoeia Commission of PRC. Chinese Pharmacopoeia, 2010 edn. Beijing: China Medical Science And Technology Press, 2010: 1-30.
5. Çelebi ZK, et al. Crataegus tanacetifolia leaf extract prevents L-NAME-induced hypertension in rats: a morphological study. Phytother Res 2006; 20: 66-70.
6. Dalli E, et al. Hawthorn extract inhibits human isolated neutrophil functions. Pharmacol Res 2008; 57: 445-450.
7. Leuchtgens H,. Crataegus special extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double-blind study. Fortschr Med 1993; 111: 352-354.
8. Weikl A, et al. Crataegus special extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II). Fortschr Med 1996; 114: 291-296.
9. Ding XP, et al. Quality and antioxidant activity detection of Crataegus leaves using on-line high-performance liquid chromatography with diode array detector coupled to chemiluminescence detection. Food Chem 2010; 120: 929-933.
10. Ying XX, et al. HPLC determination of eight polyphenols in the leaves of Crataegus pinnatifida Bge. var. major. J Chromatogr Sci 2009; 47: 201-205.
11. Ying XX, et al. HPLC determination of malondialdehyde in ECV304 cell culture medium for measuring the antioxidant effect of vitexin-4″-O- glucoside. Arch Pharm Res 2008; 31: 878-885.
12. Ying XX, et al. LC determination of malondialdehyde concentration in the human umbilical vein endothelial cell culture medium: application to the antioxidant effect of vitexin-2″-O-rhamnoside. Chromatographia 2008; 67: 679-686.
13. Ninfali P, et al. Characterization and biological activity of the main flavonoids from Swiss Chard (Beta vulgaris subspecies cycla). Phytomedicine 2007; 14: 216-221.
14. Li HB, et al. The mechanism of vitexin-4″-O-glucoside protecting ECV-304 cells against tertbutyl hydroperoxide induced injury. Nat Prod Res 2010; 24: 1695-1703.
15. Chen YH, et al. Hepatic and gastrointestinal first-pass effects of vitexin-4″-O-glucoside in rats. J Pharm Pharmacol 2013; 65: 1500-1507.
16. Ma G, et al. Simultaneous determination of vitexin-4″-O-glucoside and vitexin-2″-O-rhamnoside from hawthorn leaves flavonoids in rat plasma by HPLC method and its application to pharmacokinetic studies. J Pharm Biomed Anal 2007; 44: 243-249.
17. Ying XX, et al. Pharmacokinetics of vitexin-4″-O-glucoside in rats after intravenous application. Eur J Drug Metab Pharmacokinet 2012; 37: 109-115.
18. Chen YH, et al. HPLC determination of vitexin-4″-O-glucoside in mouse plasma and tissues after oral and intravenous administration. J Liq Chromatogr Relat Technol 2014; 37: 1052-1064.
19. Liang MJ, et al. Quantitative LC/MS/MS method and in vivo pharmacokinetic studies of vitexin rhamnoside, a bioactive constituent on cardiovascular system from hawthorn. Biomed Chromatogr 2007; 21: 422-429.
20. Ying XX, et al. Determination of vitexin-2″-O-rhamnoside in rat plasma by ultra-performance liquid chromatography electrospray ionization tandem mass spectrometry and its application to pharmacokinetic study. Talanta 2007; 72: 1500-1506.
21. Bi J, et al. Protective effects of catalpol against H2O2-induced oxidative stress in astrocytes primary cultures. Neurosci Lett 2008; 442: 224-227.
22. Zhang Y, et al. Effects of Rehmannia glutinosa oligosaccharide on human adipose-derived mesenchymal stem cells in vitro. Life Sci 2012; 91: 1323-1327.
23. Curtin JF, et al. Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 2002; 265: 49-72.
24. Halliwell B,. Oxidative stress and cancer: have we moved forward? Biochem J 2007; 401: 1-11.
25. Valko M, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
26. Singh N, et al. Oxidative stress and heart failure. Mol Cell Biochem 1995; 147: 77-81.
27. Ramond A, et al. Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia. Fundam Clin Pharmacol 2013; 27: 252-261.
28. Folli F, et al. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev 2011; 7: 313-324.
29. Giacco F, Brownlee M,. Oxidative stress and diabetic complications. Circ Res 2010; 107: 1058-1070.
30. Zuk PA, et al. Multilineage cells from human adipose tissue: implication for cell-based therapies. Tissue Eng 2001; 7: 211-228.
31. Gimble JM, et al. Adipose-derived stem cells for regenerative medicine. Circ Res 2007; 100: 1249-1260.
32. Tobita M, et al. Adipose-derived stem cells: current findings and future perspectives. Discov Med 2011; 11: 160-170.
33. Li F, et al. Gui-ling-gao, a traditional Chinese functional food, prevents oxidative stress-induced apoptosis in H9c2 cardiomyocytes. Food Funct 2013; 4: 745-753.
34. Radad K, et al. Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration. Neurochem Int 2006; 49: 379-386.
35. Kruman I, et al. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 1997; 17: 5089-5100.
36. Jang S, et al. Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin. BMC Cell Biol 2010; 11: 25-37.
37. Walton M, et al. Annexin-V labels apoptotic neurons following hypoxia-ischemia. Neuroreport 1997; 8: 3871-3875.
38. Hu L, et al. Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax. Eur J Pharmacol 2010; 628: 155-163.
39. Lesnefsky EJ, et al. Iron-catalyzed reactions cause lipid peroxidation in the intact heart. J Mol Cell Cardiol 1992; 24: 1031-1038.
40. Nakamura H, et al. Redox regulation of cellular activation. Annu Rev Immunol 1997; 15: 351-369.
41. Creagh EM, et al. Caspases: cellular demolition experts. Biochem Soc Trans 2001; 29: 696-702.
42. Earnshaw WC, et al. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-424.
43. Snigdha S, et al. Caspase-3 activation as a bifurcation point between plasticity and cell death. Neurosci Bull 2012; 28: 14-24.
44. Lu YH, et al. Protective effects of the citrus flavanones to PC12 cells against cytotoxicity induced by hydrogen peroxide. Neurosci Lett 2010; 484: 6-11.
45. Zhu XX, et al. The protective effects of vitexia-rhamnoside (VR) on the cultured cardiacmyocytes damaged by hypoxia and reoxygenation. Chin J Nat Med 2003; 1: 44-49.
46. Zhu XX, et al. Effect of vitexia-rhamnoside (VR) on vasomotor factors expression of endothelial cell. China J Chin Mater Med 2006; 31: 566-569.
47. Li P, et al. Effect of haw leaf extract and its preparation on polymorphonuclear leucocyte adhesion during HUVEC anoxia/reoxygenation injury. Chin J Integr Tradit West Med 2008; 28: 716-720.